Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Safety, Pharmacodynamic, and Antitumor Activity of Tidutamab, an SSTR2 x CD3 Bispecific Antibody, in Subjects With Advanced Neuroendocrine Tumors
Safety, Pharmacodynamic, and Antitumor Activity of Tidutamab, an SSTR2 x CD3 Bispecific Antibody, in Subjects With Advanced Neuroendocrine Tumors El-Rayes, B. F., Hendifar, A. E., Pant, S., Wilky, B. A., Reilley, M. J., Benson, A. B., Chow, W. A., Konda, B., Starr, J., Ahn, D. H., Kunz, P. L., Strosberg, J. R., Eads, J. R., Perez, K. J., Raj, N. P., Fisher, G. A., Chollate, S., Fleener, C. A., Ding, Y., Tang, Z. LIPPINCOTT WILLIAMS & WILKINS. 2022: E58View details for Web of Science ID 000819123700109